Cardiologs Holter Platform vs prolaio eVO2peak Module
AI Verdict
Choose Cardiologs Holter Platform if…
Choose the Cardiologs Holter Platform if your cardiology practice requires a highly efficient, AI-powered solution for comprehensive arrhythmia detection from traditional Holter ECGs. This cloud-based platform is ideal for streamlining cardiac diagnostics, reducing analysis time, and integrating seamlessly with your EMR for enhanced workflow and reporting.
View Cardiologs Holter Platform →Choose prolaio eVO2peak Module if…
Choose the prolaio eVO2peak Module if your focus is on estimating peak oxygen consumption (eVO2peak) for cardiovascular fitness assessment, rehabilitation, or research, utilizing real-world data from FDA-cleared wearable sensors. This tool is best suited for clinicians and researchers who need an adjunctive aid to evaluate patient cardiovascular health through continuous, longitudinal data collection.
View prolaio eVO2peak Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiologs Holter Platform | prolaio eVO2peak Module |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud | Cloud-based (software-only, processes remote sensor data) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiologs Holter PlatformTool A offers significant usability benefits by reducing Holter analysis time by approximately 42% and providing an ergonomic, cloud-based interface for efficient workflow and easy-to-read, automatically enriched reports. Tool B, while designed for safe integration, is described as lacking a direct user interface, focusing more on backend data processing from external sensors.
Clinical Value
Cardiologs Holter PlatformTool A provides broad diagnostic support by detecting over 20 types of arrhythmias and has demonstrated a 42% reduction in Holter analysis time, along with improved accuracy in detecting specific arrhythmias like AF and VT [JSON, 4]. Tool B offers a valuable, specific metric (eVO2peak) as an adjunctive aid in clinical evaluation, validated through clinical studies, but its scope is narrower compared to Tool A's comprehensive arrhythmia detection [JSON, 2].
Pricing & Value
Cardiologs Holter PlatformTool A offers a more transparent pricing model, specifying 'Pay per ECG regardless the number of users' [JSON, 4]. This provides a predictable and scalable cost structure for healthcare providers. Tool B only states 'contact for pricing' [JSON], offering no public details on its pricing model.
Enterprise Readiness
Cardiologs Holter PlatformTool A demonstrates superior enterprise readiness with explicit EMR integration via Philips IntelliBridge Enterprise and secure data hosting on ISO/IEC 27001 certified AWS servers [JSON, 1, 14]. Both tools are FDA-cleared, HIPAA compliant, and cloud-based, but Tool B lacks specific details on EMR integration or advanced security certifications in the provided information [JSON].
Innovation
TieBoth tools showcase significant innovation. Tool A pioneered medical-grade deep learning AI for ECG analysis, being the first FDA-cleared solution of its kind, and offers vendor-neutral compatibility for Holter analysis. Tool B's innovation lies in its novel approach to estimating peak oxygen consumption (eVO2peak) from real-world, multi-modal sensor data collected from third-party wearables, providing a unique adjunctive aid for cardiovascular assessment [JSON, 2, 8].
Support & Docs
Cardiologs Holter PlatformTool A provides more explicit details regarding support and documentation, including direct instructions to access technical support via its platform's 'Help' menu and mentions of product manuals, brochures, and white papers. While Tool B mentions documentation for integration and contact information, Tool A's offerings appear more comprehensive and readily accessible for users seeking support and resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiologs Holter Platform | prolaio eVO2peak Module |
|---|---|---|
| Primary Function | AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias. | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. |
| Company | Philips France Commercial | Prolaio |
| Key Technology | AI-powered deep learning technology for ECG analysis | Locked deep-learning model for eVO2peak estimation; proprietary algorithms |
| Input Data/Devices | Holter ECG (vendor-neutral compatibility with multiple Holter devices) | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors |
| Output/Analysis Focus | Detects over 20 types of arrhythmias; generates easy-to-read, automatically enriched reports | Estimates peak oxygen consumption (eVO2peak); provides information as an adjunctive aid in clinical evaluation |
| Integration Capabilities | Integration with Electronic Medical Record (EMR) systems (Philips IntelliBridge Enterprise) | Processes data from qualified third-party FDA-cleared wearable medical sensors |
| Data Security/Hosting | Secure data hosting on ISO/IEC 27001 certified AWS servers | Not specified |
| Target Specialties | Cardiology | Cardiology, Physical Medicine & Rehab, Sports Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cardiologs Holter Platform and prolaio eVO2peak Module.